Aminoglycosides Summary is organized by CEUfast, Inc. and will be held from Nov 27, 2018 - Feb 01, 2020.
The target audience for this medical event is for Advanced Registered Nurse Practitioner (ARNP), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Registered Nurse (RN). This CME Conference has been approved for a maximum of 2.0 Contact Hours.
In this educational program we will concentrate specifically on the aminoglycoside class of antibiotics which consists of many different agents including amikacin sulfate, gentamicin sulfate, neomycin sulfate, paromomycin, streptomycin and tobramycin sulfate. Of these, gentamicin, tobramycin and amikacin are the most frequently prescribed.
After completing this educational program, the learner will be able to meet the following 15 objectives:
• Describe the mechanism of action and spectrum of activity of the aminoglycosides.
• Relate the development of resistance demonstrated by the aminoglycosides.
• Compare and contrast the clinical indications of aminoglycosides in terms of monotherapy, combination antibacterial therapy and antimycobacterial therapy.
• Describe the specific patient parameters which should be assessed prior to the administration of any aminoglycoside.
• Differentiate between the traditional intermittent and extended-interval dosing strategies used when prescribing parenteral aminoglycosides and the pros and cons underlying each dosing strategy.
• Describe the general principles underlying the administration of parenteral aminoglycosides and the roles dosing weight and creatinine clearance play in aminoglycoside dosing.
• Describe the follow-up evaluation of patients taking aminoglycosides.
Medicine, Immunology and Microbiology, Biochemistry and Molecular Genetics